A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

Calcium in the aortic valve by itself may not cause problems, but it can keep the valve from being able to open all the way, ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Anteris Technologies Global Corp.’s AVR share price has dipped by 5.20%, which has investors questioning if this is right ...

For over a decade, the McGill University Health Centre (MUHC) has been at the forefront of aortic valve innovation, advancing ...

Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older ...

The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Anteris Technologies Global Corp.’s AVR share price has surged by 12.25%, which has investors questioning if this is right time to sell.